“Mad Money” host Jim Cramer is telling you what we could see when earnings season kicks off next week.» Read More
JJ Burns, JJ Burns & Company president & CIO, and Bob Keiser, S&P Capital IQ VP of global markets intelligence, discuss today's lag in financials and whether they are seeing the earnings they expected.
Dennis Gartman, The Gartman Letter founder, editor & publisher, and Ralph Acampora, Altaira Limited, evaluate stock market action and discuss when they think the bull market will end.
Is there a reason to avoid Facebook? Aaron Kessler, Raymond James, and Brian Evans, AdvisorShares, debate the play on the social media giant. Kessler recently increased his price target to $63 from $60.
CNBC's Rick Santelli discusses inflation and the velocity of money. Bill Griffeth and Kelly Evans look back at one of Santelli's first guest spots on CNBC.
Discussing today's sell off and the financial sectors lag on the market, with Gina Sanchez, Chicago Global; Jim Lowell, Adviser Investments; Greg Ip, The Economist; and Ryan Detrick, Schaeffer's Investment Research.
CNBC's Seema Mody looks at three stocks to watch tomorrow, including Illumina, which was up after unveiling a genome sequencer this week; Tesla, which received an upgrade today; and Morgan Stanley, which reports earnings tomorrow.
CNBC's Bob Pisani weighs in on the saga surrounding Nu Skin and looks at some beat up stocks that are turning things around.
Discussing the state of the big banks and Citi's earnings miss, with Steven Chubak, Nomura, and Neil Weinberg, American Banker editor-in-chief.
The FMHR traders reveal their final trades of the hour.
Eric Jackson, Ironfire Capital founder & managing partner, explains why he thinks it would be a good move for Yahoo to acquire AOL. discusses Marissa Mayer's announcement that Henrique De Castro is out as Yahoo's COO.
FMHR traders Jon Najarian and Steve Weiss debate the play on Yahoo. Dr. J says Alibaba will drive value. Weiss says everything that is good with Yahoo was good before Mayer got there.
United Health sells of despite beating Q4 estimates, and Solar City shares rally. The FMHR traders share their strategies to playing the stocks.
Mark Schoenebaum, ISI Group analyst, breaks down the red hot biotech sector and explains why Gilead Sciences is his best play.
CNBC's Courtney Reagan reports Best Buy's stock is getting pounded after holiday sales dropped nearly 1 percent. The FMHR traders weigh in on the scuffling retailer.
Islamic bond issues could hit record levels this year, Fitch said on Thursday — the same day as Qatar launched a $3 billion issue of "sukuks".
With rising rates, it's no surprise to see a considerable short in the Treasury market.
Joe Feldman, Telsey Advisory Group assistant director of research, discusses Best Buy's holiday sales miss and explains his optimistic outlook. "Best buy is a highly relevant retailer and will be for some time," Feldman says.
Confidence among home builders fell one point in January after a big jump in December. CNBC's Diana Olick breaks down the NAHB data.
CNBC's Bob Pisani looks ahead at what's likely to move this morning's markets as bank stocks begin to pullback in early trading.
This is a sample of what happens when you get way too bullish ahead of a quarter, says Jim Cramer, sharing his thoughts on shares of Best Buy plummeting after reporting its U.S. comp sales for the holiday season, which were down 0.9 percent.